Floriano Marchetti, MD
Colon & Rectal Surgery · Miami, FLNPI 1922063882
Payments from drug & device makers
Across 28 payments — averaging $163.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$1K
- Medtronic$1K
- Covidien LP$575
- Intuitive Surgical$573
- Innovation Technologies Inc$357
- THD America, Inc.$278
- plus $598 from 8 others
What the payments were for
- Consulting fees$1,67537%
- Travel & lodging$1,08824%
- Food & beverage$1,74638%
- Education$752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 3 | $1,102 |
| Medtronic | 1 | $1,100 |
| Covidien LP | 1 | $575 |
| Intuitive Surgical | 8 | $573 |
| Innovation Technologies Inc | 3 | $357 |
| THD America, Inc. | 3 | $278 |
| Integra Lifesciences Corporation | 1 | $139 |
| Johnson & Johnson | 2 | $128 |
| Celularity Inc. | 1 | $109 |
| Mallinckrodt Enterprises LLC | 1 | $107 |
| Conmed Corporation | 1 | $57 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Baudax Bio Inc. | 1 | $21 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOYANT$1,088
- LigaSure$575
- Irrisept$316
- Da Vinci Surgical System$282
- BIOFIX$139
- BIODRESTORE$139
- MEDIHONEY$139
- BIODOPTIX$139
- BIODFACTOR$139
- OFIRMEV$107
- HARMONIC Product Family$101
- Enseal X1 5mm$101
- STRATAFIX$101
- EVICEL Fibrin Sealant (Human)$101
- Surgicel Powder$101
How this compares
$4,584 in reported general payments places this provider in the 45th percentile of 157 colon & rectal surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 13 | $55 |
| Metronidazole | 17 | $47 |
| Meloxicam | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Miami
- Henry LujanMiami$378K
- Luis HernandezMiami$220K
- Laurence SandsMiami$47K
- Gustavo PlasenciaMiami$46K
- Marianna ZeichenMiami$44K
- Andrea MadiedoMiami$38K
- Eduardo KrajewskiMiami$29K
- Marcos SzomsteinMiami$22K
- Gustavo RubioMiami$14K
- Mark SolimanAltamonte Springs$887K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.